酪氨酸激酶抑制剂相关治疗药物监测的研究进展(11)
[73] BENCE AK，ANDERSON EB，HALEPOTA MA，et al. Phase Ⅰ pharmacokinetic studies evaluating single and multiple doses of oral GW572016，a dual EGFR-ErbB2 inhibitor，in healthy subjects[J]. Invest New Drugs ......
您现在查看是摘要页，全文长 1728 字符。